Next-Gen Antiviral Drugs: Navigating Global Demand and Market Innovation
The global healthcare landscape faces a persistent challenge: the rapid evolution of viral pathogens and the growing threat of treatment resistance. From seasonal influenza outbreaks to chronic viral infections like hepatitis and HIV, clinical care relies heavily on effective therapeutic interventions. However, legacy therapeutics often struggle with mutation-driven evasions, narrow efficacy...